Liposome doxorubicin

DRUG2 trials

Sponsors

Clinical Service, China, Sun Yat-sen University

Conditions

Desmoid TumorMultiple MyelomaPlasma Cell Leukemia

Phase 2

Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia

Clinical Service, ChinaMultiple Myeloma, Plasma Cell Leukemia

Start: 2010-09-30End: 2015-09-30Target: 20Updated: 2011-09-22

Phase 3

A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor

Sun Yat-sen UniversityDesmoid Tumor

Start: 2020-09-29End: 2023-03-01Target: 72Updated: 2022-09-30